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 AB S T R A CT   
Bis 2-Hydroxy Ethyl Terephthalate-based biodegradable poly(mannitol-citric-sebacate) 
has been synthesized by catalyst-free melt condensation process using two different 
diacids and Bis 2-Hydroxy Ethyl Terephthalate with D-mannitol as monomers having a 
potential to be metabolized in vivo. The biocompatibility of the polymer, Bis 2-Hydroxy 
Ethyl Terephthalate-poly(mannitol-citric-sebacate) has been tested using human primary 
stromal cells. In vitro degradation of Bis 2-Hydroxy Ethyl Terephthalate-poly(mannitol-
citric-sebacate) polymer in Phosphate Buffered Saline solution carried out at 
physiological conditions indicates that the degradation goes to completion after 23 days. 
The usage of Bis 2-Hydroxy Ethyl Terephthalate-poly(mannitol-citric-sebacate) polymer 
as a drug carrier has been analyzed by doping the polymer with Doxorubicin model drug 
and the release rate has been studied by mass loss over time. The cumulative drug-
release profiles exhibit a biphasic release with an initial burst release and cumulative 100 
percent release within 14 days. 
Keywords: Bis 2-Hydroxy ethyl terephthalate poly(mannitol-citric-sebacate), 
Biodegradable Polymer, Human Primary Stromal Cells, Biocompatibility, Scaffold, 
Drug-delivery. 
 
1. Introduction 
Target release and sustained release could not be 
expected usually in conventional oral and 
intravenous drug administration [1]. Drug-
delivery devices aid in the controlled release by 
providing therapeutic drug levels, restricting the 
drug-delivery to a specific site within the body 
and reducing the number of re-administrations 
during treatment [2].  
 
 
 
Recently, the use of biodegradable polymers in 
the drug-delivery implants has gained much 
attention. The use of biodegradable polymer–
drug implant systems for controlled release and 
target specificity in treating cancers and tumors 
has been studied and shown promising results 
[3]. Among the biodegradable polymers, 
aliphatic polyesters are used as drug-delivery 
carriers in local drug-delivery systems for in vivo 
applications due to their degradability and 
biocompatibility [4]. Some of the aliphatic 
polyesters have biodegradation times varies 
from weeks to years [5].  
Received: 23 April 2016   Revised: 05 June 2016    Accepted: 16 June 2016  Published: 20 June 2016 
* Corresponding author: athiraiisc@gmail.com  
   DOI: http://dx.doi.org/10.21467/jmm.1.1.9-16  
 ISSN: 2456-4834 
Available online at Journals.aijr.in 
10 
Synthesis, Degradation, Biocompatibility and Drug Release Studies of Bis 2-Hydroxy Ethyl Terephthalate-based Poly(Mannitol-Citric-Sebacate) Ester 
One of the most commonly used anticancer 
agents is 5-Fluorouracil (5-FU), but it is poorly 
absorbed after oral administration and thus local 
drug-delivery is the ideal way to overcome this 
disadvantages [6]. It is also one of the 
commonly used Doxorubicin (Dox) containing 
regimens and is available for clinical use in 
limited supply. Human primary stromal cells or 
mesenchymal stem cells produced by expanding 
bone marrow mononuclear cells in culture can 
be used for biocompatibility studies. The usage 
of these polymers in the biomedical field 
becomes common due to its degradation in 
physiological conditions inside the human body 
[7]. As temporary implants, they can stay intact 
until the healing process is complete; 
subsequently, they degrade and are excreted 
from the body as waste products [8].  
Currently, typical commercially available 
chemosynthetic biomedical adhesives are 
cyanoacrylate adhesive (Dermabond R), 
aldehyde-based adhesive (GRF glue R) and 
fibrin-based adhesive (Bolheal R). Cyanoacrylate 
and aldehyde-based adhesives provide strong 
bonding, though cytotoxicity is relatively high. A 
fibrin-based adhesive is known to have a 
relatively low cytotoxicity but have an inferior 
bonding strength. Biodegradable adhesives were 
derived from citrate, malate and tartrate as 
organic acid-based crosslinkers. Excellent 
bonding strength, reactivity and bonding time 
were reported when using disuccinimidyl tartrate 
(DST) as a crosslinker and human serum 
albumin (HSA) as a hardener for the muscle of 
porcine, with the bonding strength being 
equivalent to that of cyanoacrylate-based 
adhesive [9]. Inoue et al. [10] artificially created 
to use the novel DST–HSA biological adhesive 
for repairing the longitudinal tear of the 
avascular zone of the meniscus, investigated the 
optimum usage and evaluated the effectiveness 
and safety using animal models. Many matrix 
types, which combine synthetic and natural 
materials, are able to enhance biocompatibility 
and biofunctionality and their blending into 
synthetic polymers improves the overall 
cytocompatibility of the scaffolds [11]. Inthanon 
et al. [12] reported on the design and fabrication 
of a synthetic scaffold, composed of a minimum 
of 90% sericin, a natural glue-like protein from 
Bombyx mori silkworm cocoons, and Poly(L-
lactic-co-𝜀-caprolactone) as an effective 
substrate for the proliferation of 
undifferentiated Human Wharton’s jelly 
mesenchymal stem cells, derived from umbilical 
cords and can be used in drug delivery and the 
controlled release of growth factor. 
Biodegradable aliphatic polyesters are the 
preferred choices of materials for in vivo 
applications due to their degradability and 
biocompatibility [5]. Aliphatic polyesters have 
better degradation properties than aromatic 
esters as the aromaticity provides the 
hydrophobicity. Although many biodegradable 
materials, including polyesters, have been 
developed [13], most of them require stringent 
operating conditions, catalyst/initiators and 
multiple steps during synthesis and suffer from 
rigid mechanical properties and long degradation 
times [5]. It has been shown that poly (b-
hydroxy octanoate) was not significantly 
degraded even after two years in an animal body 
[14]. The osmolarity and ion concentrations of 
Phosphate Buffered Saline (PBS) match with 
those of the human body (isotonic). PBS 
maintains a steady pH and acts as non-toxic to 
cells so that the cells are not destroyed.  
2. Materials and Methods 
2.1 Synthesis of Bis 2-Hydroxyethyl 
terephthalate-based poly(mannitol-citric-
sebacate) ester 
Sebacic acid, Citric acid, D-Mannitol and Bis 2-
Hydroxyethyl terephthalate (BHET) have been 
purchased from S.D Fine Chemicals Ltd., India. 
BHET polyesters have been synthesized by melt 
condensation polymerization technique using 
the above monomers, as shown in Figure 1. In 
the glass tube kept on the stand; 6 g of Sebacic 
acid, 7.5 g of BHET and 2.85 g of citric acid 
have been taken. A magnetic bead has been put 
in the glass tube and inserted a needle with the 
rubber stopper to maintain it closed and kept 
the tube in the oil. Temperature has been set to 
160°C on the heater to form a molten solution 
as the melting point of sebacic acid is around 
133°C, while that of BHET is around 110°C and 
that of citric acid is 153°C. 1.35 g D-Mannitol is 
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added only after 1.5 hours due to the lower 
reactivity of BHET than D-Mannitol and the 
total polymerization took 2 hours, which is 
noted only after the liquefaction of the entire 
material.  
 
 
Figure 1: Synthetic scheme of the synthesis of 
BHET polyester 
 
After complete melting of solids, the solution is 
allowed to react for 1 hour with continuous 
stirring by setting rotation speed to 3 rpm. 
During the reaction, nitrogen gas is continuously 
purged through the glass tube to provide an 
inert atmosphere and aid the removal of water 
formed during the reaction. The prepolymer is 
taken directly for polymer–drug implant studies. 
For preparing the drug-loaded polymers, the 
prepolymer and drug have been dissolved in 
ethanol and subsequently, ethanol is evaporated. 
The prepolymers are post-polymerized in a 
vacuum oven for 2 days at 1000°C and 560 mm 
Hg to form cross-linked polyesters. The cured 
polymers have been used for drug-delivery, 
degradation and biocompatibility studies. 1H-
NMR spectra for the polymer has been recorded 
on an NMR spectrometer at 400 MHz using 
acetone as solvent and tetramethylsilane as the 
internal reference. The prepolymer has been 
purified by dissolving the polymers in 20 wt% 1, 
4-dioxane and precipitated in 3 vol% water–
propanol non-solvent mixture with continuous 
agitation, followed by filtration and freeze-
drying at –90°C. The cured polymer is subjected 
to Fourier Transform Infra-Red (FTIR) analysis 
by scanning thin films made out of cured 
polymer and KBr crystals using FTIR 
spectrometer over the 4000–500 cm–1 range IR 
spectrum, at room temperature. 
2.2 Preparation of Phosphate Buffer Saline 
1x PBS, which corresponds to 1 ml PBS is used 
and prepared as per Cold Spring Harbor 
Protocol [15]. 800 ml of Milli-Q-water has been 
measured with a graduated cylinder and 
transferred to an Erlenmeyer flask. 8 g of NaCl, 
0.2 g KCl, 1.44 g of Na2HPO4 and 0.24 g of 
KH2PO4 are also transferred to the flask. 3 to 5 
mins proper stirring is given allowing the solutes 
to dissolve so that oxygen is not introduced into 
the solution while it is rapidly mixed. it is 
ensured that there are no remaining particles of 
undissolved salts in the solution before adjusting 
the pH. If particles are present, stirring is 
continued at reduced speed to get solution 
gently mixed. Properly calibration of the pH 
meter has been ensured and rinsed the pH 
probe with Milli-Q-water. The probe tip has 
been cleaned with a paper towel without 
touching it. pH probe is inserted into the 
solution and slowly added 1 M HCl, drop wise 
with a transfer pipette and allowed the HCl to 
fully dissolve into the solution. Stopped stirring 
the solution and measured the pH with the pH 
meter. Repeated above steps until the pH of the 
solution become 7.4. The resultant solution has 
been poured into a freshly graduated cylinder 
and adjusted the final volume to 1 liter with 
Milli-Q-water. 
2.3 In vitro degradation 
Phosphate buffer saline solution of pH 7.4 has 
been prepared using monosodium diphosphate 
and disodium phosphate (S.D. Fine Chemicals 
Ltd., India) with fine adjustment of pH using 
diluted NaOH. The square shaped polymer 
specimens of side 8-10 mm and 1.5-2 mm 
thickness has been immersed in 15 ml of 
phosphate buffer solution and maintained at 
370°C in a water bath with continuous agitation. 
At specified intervals of time, the polymer 
specimens have been taken out, washed with 
Milli-Q-water and dried to constant weight 
under vacuum. The percent degradation of the 
polymers in buffer saline solution has been 
calculated by mass loss over time. 
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2.4 Scaffold fabrication 
Porous scaffold from the polyester has been 
fabricated using the salt-leaching technique 
utilizing the solubility of the prepolymer in 
different solvents [16]. The prepolymer has been 
dissolved in 1, 4-dioxane separately to form 25 
weight percent solution. Sieved salt is added to 
this solution to get a 25 percent w/v slurry. The 
slurry has been transferred to Teflon moulds 
and the solvent is allowed to evaporate slowly at 
90°C. After solvent evaporation for 24 h, the 
moulds are transferred to a vacuum oven and 
the polymers are cured at 560 mm Hg vacuum 
and 100°C for 3 days. The cured salt filled 
polymers have been demoulded and cut into 
square pieces of side 8-10 mm. These samples 
are leached out of salt by incubating the polymer 
in Milli-Q-water and replacing the water 
medium every 12 h for 4 days. The resulting 
porous polymer has been freeze-dried at –90°C 
and stored in desiccators. 
2.5 Cell Culture 
The cytotoxicity test for evaluating the 
biocompatibility of a polymer in which the 
toxicity effect on the human cells due to the 
presence of the polymer or its degradation 
products is studied [17]. Initially, the polymer 
specimen of size, 10 mm × 2 mm has been 
sterilized by rinsing with absolute ethanol and 
UV radiation for 30 mins. The source used for 
UV radiation is FS20 lamp with a Kodacel filter, 
emitting UVB spectrum of 280-320 nm 
wavelength at a lower dose. Human primary 
stromal cells or mesenchymal stem cells have 
been used in this study for evaluating the 
biocompatibility. These cells have been grown in 
high-glucose Dulbecco’s Minimal Essential 
Medium (DMEM; Sigma) supplemented with 
Invitrogens such as 10 percent (v/v) fetal bovine 
serum, 100 μg/ml streptomycin and 100 μg/ml 
penicillin [18]. After growth, these cells have 
been harvested using trypsin 0.025 
percent/EDTA 0.01 percent, and these cells 
have been re-suspended by adding an equal 
volume of the medium. The suspended cells in 
the medium have been seeded in two 
polystyrene sterile tissue-culture dishes at a very 
low density of 15–20 percent confluence, and 15 
ml of DMEM medium supplemented with FBS, 
streptomycin and penicillin are added. One petri 
dish served as the negative control and the other 
dish is loaded with sterilized polymer sample to 
study the cytotoxicity effect of the polymer. 
Both the disks are incubated at 37°C and 5 
percent CO2, and the cells have been allowed to 
grow to form a confluent monolayer. The cells 
have been observed for growth in the dish 
through an inverted microscope every two days 
and the medium is replaced with a fresh medium 
on alternate days for a week. 
2.6 Drug-release Studies 
The required quantity of drug, Dox has been 
added to the polymer. Three bags have been 
made using a wire net. Three square pieces of 
the same measurements have been cut out from 
the polymer-drug matrix. Each bag is kept in the 
balance and after taring the balance, one piece of 
the polymer has been put into each bag and 
weighed. Put the bags with the polymer-drug 
matrix in PBS buffer with 15 ml each and 
incubated it at 370°C under shaking. 1 ml of the 
buffer is taken at specified intervals of time and 
added back 1 ml of PBS buffer to the samples. 
Samples have been taken at different intervals of 
time. The absorbance of each of these samples 
is measured at 544 nm using a 
spectrophotometer till the absorbance reading 
comes to a standstill. The drug–polymer matrix 
samples have been analysed for drug-loading 
efficiency. Small cured polymer–drug matrix 
discs have been weighed and placed in 100 ml of 
basic NaOH solution and allowed for complete 
dissolution of the polymer and the drug. The 
supernatant liquid has been analysed for the 
drug quantity using the absorbance level at the 
respective λmax for the drug, measured with a 
UV–Vis spectrophotometer. The percent 
degradation of the polymers in buffer saline 
solution has been calculated by comparing mass 
loss over time and graph is plotted. 
3. Results and Discussion 
3.1 Polymer synthesis 
Bis 2-Hydroxyethyl terephthalate-based 
poly(mannitol-citric-sebacate) ester; abbreviated 
as BHET-p(MCS) has been synthesized without 
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the use of catalyst or initiators and hence 
expected of less or nil toxicity. On subsequent 
curing under controlled conditions, the reaction 
attains completion and forms a solid mass, 
which is highly cross-linked and not soluble in 
any solvent. Despite the small quantity of 
BHET, cross-linked structures are formed due 
to the tri-functionality of BHET and the 
polymer becomes cross-linked after curing. The 
NMR spectrum for this prepolymer is shown in 
figure 2 and has common peaks for many of its 
monomers. All the monomers are incorporated 
in the polymer because the mass loss during 
curing is less than 1.8%. The peaks of Sebacic 
acid CH2 group and D-Mannitol CH and CH2 
groups are merged with similar groups available 
in BHET. Thus, qualitative analysis can not use 
for determining the monomer ratio in the 
prepolymer. 
 
Figure 2: 1H-NMR spectra of BHET-p(MCS) in 
acetone 
FTIR spectrum for the synthesized BHET-
p(MCS) cured polymer is shown in figure 3. The 
peaks for the specific functional groups in the 
IR spectrum such as Ester C=O group 
stretching, double bond C=C and the C–H 
bending of end methyl group are identified and 
seen correspond to wave numbers 700-2930 
reciprocal centimetres. 
 
Figure 3: FTIR spectrum of Cured BHET-p(MCS) 
polymer 
3.2 In vitro degradation 
Aliphatic, biodegradable polyesters start 
degrading when placed in an aqueous medium 
due to hydrolysis. The degradation behaviour of 
the polyester can be analyzed by the change in 
solution viscosity, molecular weight, as well as 
mass-loss measurement methods [19]. Since the 
synthesized cured polymer is cross-linked, the 
first two methods cannot be used and thus 
mass-loss measurements has been carried out to 
determine the degradation behaviour. The in 
vitro degradation of the polymer has been 
observed through the variation of the weight 
loss of the polymer with incubation time and the 
time for complete degradation of the polymer 
which is more than 23 days as given in table 1.   
 
Table 1: BHET-p(MCS) degradation profile in 
PBS solution at pH 7.4 
Incubation time 
(days) 
5 10 15 20 23 
Weight loss of 
polymer (%) 
44 58 67 75 78 
 
The degradation mechanism of the polymer in 
aqueous medium involved a combination of 
chemical reaction, diffusion and dissolution 
process. These include the following processes 
viz., water sorption; and reduction of modulus, 
strength, molar mass and weight. More 
hydrophilic backbone and end-groups; reactive 
hydrolytic groups in the backbone; porosity; less 
crystallinity and smaller size accelerate 
degradation mechanism. The mechanism begins 
with water diffusion followed by a stage in 
which oligomers with acidic end-groups 
autocatalyzed the hydrolysis reaction. A critical 
molecular weight is reached and oligomers start 
to diffuse out from the polymer. Water 
molecules diffuse into the void created by the 
removal of the oligomers which in turn 
encourages oligomer’s diffusion. Marked 
decrease in polymer mass and a sharp increase in 
the oligomer diffusion rate occur as the 
oligomers diffuse from the porous regions. 
Polymeric matrix become highly porous and 
degradation proceeds homogeneously and 
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becomes slower until complete degradation of 
the polymer. 
3.3 Scaffold fabrication 
BHET-p(MCS) polymer has been fabricated as a 
porous sponge like scaffold by the salt leaching 
technique. The scaffold shows macro- and 
micropores between the polymer networks with 
the size of 18±12 μm (Figure 4) for the latter. 
These interconnected micropores will serve as a 
passage route for the nutrients, deep inside the 
polymer scaffold, which is required for cell 
growth in tissue engineering [17]. The scaffold 
type of polymer network can be utilized in 
various vascular graft or tissue-engineering 
applications. For tissue-engineering applications, 
the excess hydroxyl or carboxyl groups available 
in the polymer backbone chain can be utilized as 
moieties for potential modification. Peptides or 
proteins can be incorporated into the polyester 
network using hydroxyl/carboxyl group 
functionalities to derive a particular cell 
response.  
 
 
Figure 4: SEM image of BHET-p(MCS) polymer 
scaffold 
3.4 Cell culture 
The performance of cells such as growth pattern 
and morphology in the presence of polymer has 
been compared with a negative control. The 
negative control in this experiment is a cell 
culture in polystyrene dish which is compatible 
with cells. It has been noticed on the second day 
of observation that the cells are attached at the 
bottom of both the dishes. The cell morphology 
is found to be similar in both the dishes and had 
a complete confluence in the dish as shown in 
figure 5. The morphology of the cells proves 
that they had survived in the presence of the 
polymer, were attached to the bottom of the 
dish and finally grew to occupy the whole area 
or full confluence. A broad range of colony 
sizes, representing varying growth rates and 
different cell morphologies, ranging from 
fibroblast-like spindle-shaped cells to large flat 
cells could be noticed. Cell debris or changes in 
morphology, such as cell lysis, loss of spindle 
shape or detachment from the bottom were not 
pronounced in the cell cultures with the 
presence of polymer. The results indicate that 
the polymer does not release any inhibitory 
leachate to the medium that is toxic and thus the 
polymer has been found to be non-cytotoxic.  
 
 
Figure 5: Morphology of Cell cultures  
5 A: A Colony Forming Unit-Fibroblast after 7 
days of culture (negative control), 
5 B: Confluent cultures after 7 days in the presence 
of BHET-p(MCS) polymer 
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3.5 Drug-delivery studies 
Loading efficiency of the drug in the polymer 
has been found to be 89 percent. The 
dissolution of the drug in the medium and the 
diffusion of the medium through the matrix, 
swelling of the polymer and cross-linked density 
also play roles in manipulating the drug-release 
profiles [19]. Figure 6 shows the cumulative Dox 
drug release profile from BHET-p(MCS)–Dox 
implants for drug loadings in the polymer. Drug 
release from the polymer implant shows that the 
release profile shows biphasic expulsions with 
burst release in the initial phase and thereafter a 
constant release controlled by degradation and 
diffusion mechanism for Dox drug. The most 
desirable release profile from a polymer–drug 
implant is a constant release rate, but most of 
the drug implants have varying release rates. The 
initial burst release of the drug is mostly due to 
the fast dissolution of the drug from the implant 
surface, as there is no requirement of diffusion 
of medium inside the implant. This behaviour 
indicates the dispersion of the drug molecules 
well in the polymer matrix. 
 
 
Figure 6: Percent drug release of Dox over time 
from BHET-p(MCS) 
 
The 75 percent cumulative drug release from the 
implants takes place within 48 h. The initial 
burst release could be due to rapid dissolution of 
drug molecules from the exposed surface. 
Similar type of initial burst behaviour has been 
observed with 5-FU drug from other polymer 
matrices and this characteristic of in vitro drug 
burst release is a common phenomenon in many 
drug-delivery systems [4]. The poly (carboxy 
phenoxy propane):sebacic acid matrix with 
Carmustine drug is a commercially available 
drug-delivery system known as ‘Gliadel’ and its 
drug-release profile also shows a similar initial 
burst behaviour [20]. The initial burst will be 
higher if it fills the surface more, whereas the 
burst release will be lower if there is also an even 
distribution of the drug inside the matrix. Thus 
the interaction of the polymer with the drug 
molecule plays a role in evenly distributing the 
drug molecule throughout the matrix. The 
distribution of Dox drug in the sample is not 
uniform throughout, with most of the drug 
available on the surface. On exposure to the 
PBS medium, the immediate dissolution of the 
drug in the medium also can be a reason for the 
rapid release. For cross-linked polymers, the 
initial hydrolysis changes the crosslink density of 
the polymer matrix, which does not necessarily 
involve weight loss. This results in an increasing 
diffusion of the medium inside the matrix and 
increased permeation rate of the drug caused by 
the gradually decreasing cross-linked density [6].  
For higher drug loadings, the initial release rate 
of the drug is smaller, which eventually increases 
in due course of time as observed in other 
polymer systems with Dox drug [4]. Smaller 
drug release may be due to the comparatively 
higher distribution of the drug inside the matrix 
and the lower initial diffusion of water inside the 
matrix. Due to the creation of free space by drug 
expulsion, the latter rate for higher loading 
matrices are increased. Li et al. [19] reported that 
as the matrix releases the drug, more void 
pathways form inside the matrix, which 
increases the diffusion of medium inside and the 
drug solution outside resulting in increased 
release profile. The availability of the medium 
inside the matrix increases the hydrolysis 
reaction, which causes faster degradation.  
4. Conclusions 
BHET-p (MCS) polymers are synthesized from 
monomers without any catalyst and extreme 
operating conditions and found to be soft and 
flexible. The study with polymer–Dox implants 
shows that the drug release has a biphasic nature 
and a mass loss of 100 percent has been 
observed in 14 days for this polymer. The 
BHET-p(MCS) polymer has good 
biocompatibility for human stromal cells, found 
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to be involved in human metabolism process, 
exhibit a fast degradation pattern in 
physiological conditions and can be used as drug 
implants for local delivery. 
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